Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

ICH Sets Three-Year Goal To Harmonize Criteria For Biowaivers

Executive Summary

ICH outlines an ambitious work plan to harmonize the disparate requirements for biowaivers among regulators worldwide; New concept paper and business plan highlight areas of disagreement.

Advertisement

Related Content

Quality Regulatory Updates In Brief: ICH, EMA, MHRA and FDA
Despite Progress, More Work Needed To Harmonize FDA and EMA Criteria For Biowaivers
ICH: India, Mexico And Russia Among New Observers; Benefit-Risk Guideline Adopted

Topics

Advertisement
UsernamePublicRestriction

Register

PS119361

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel